Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: A three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments

Cardiology Journal

Volumn 17, Issue 2, 2010, Pages 166-171

  Kaplinsky, Edgardo ^a   Comes, Francesc Planas ^a   Urondo, Ludmila San Vicente ^a   Ayma, Francesc Planas ^a  

^a Hospital Municipal de Badalona   (Spain)

Author keywords

Inappropriate sinus tachycardia; Ivabradine

Indexed keywords

IVABRADINE; ANTIARRHYTHMIC AGENT; BENZAZEPINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART PALPITATION; HOLTER MONITORING; HUMAN; INAPPROPRIATE SINUS TACHYCARDIA; QUALITY OF LIFE; SINUS TACHYCARDIA; TACHYCARDIA; DRUG EFFECTS; HEART RATE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; SPAIN; TACHYCARDIA, SINUS; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SPAIN; TACHYCARDIA, SINUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951192837     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Still AM, Raatikainen P, Ylitalo A et al. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace, 2005; 7: 104-112.
2. Morillo CA, Klein GJ, Thakur RK, Li HG, Zardini M, Yee R. Mechanisms of inappropriate sinus tachycardia. Role of sympathovagal balance. Circulation, 1994; 90: 873-877.
3. Leon H, Guzman JC, Kuusela T, Dillenburg R, Kamath M, Morillo CA. Impaired baroreflex gain in patients with inappropriate sinus tachycardia. J Cardiovasc Electrophysiol, 2005; 16: 64-68.
4. Chiale PA, Garro HA, Schmidberg J et al. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta-adrenergic receptors. Heart Rhythm, 2006; 3: 1182-1186.
5. Lee RJ, Shinbane JS. Inappropriate sinus tachycardia. Diagnosis and treatment. Cardiol Clin, 1997; 15: 599-602.
6. Krahn AD, Yee R, Klein GJ, Morillo C. Inappropriate sinus tachycardia, evaluation and therapy. J Cardiovasc Electrophysiol, 1995; 6: 1124-1128.
7. Kanjwal MY, Kosinski DJ, Grubb BP. Treatment of postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia. Curr Cardiol Rep, 2003; 5: 402-406.
8. Shen WK. How to manage inappropriate sinus tachycardia. Heart Rhythm, 2005; 2: 1015-1019.
9. DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res, 2006; 53: 399-406.
10. Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: A randomized, double-blind, multicentered, placebo-controlled trial. Circulation, 2003; 107: 817-823.
11. Tardif J-C, Ford I, Bourassa MG, Fox K. INITIATIVE Investigators. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J, 2005; 26: 2529-2536.
12. Ruzyllo W, Tendera M, Ford I, Fox KM. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: A 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs, 2007; 67: 393-405.
13. Ewan V, Norton M, Newton JL. Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine. Europace, 2007; 9: 1202.
14. Khan S, Hamid S, Rinaldi C. Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker. PACE, 2009; 32: 131-133.
15. Schulze V, Steiner S, Hennersdorf M, Strauer BE. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: A case report. Cardiology, 2008; 110: 206-208.
16. Retegui G, Quintero M, Ruiz-Borrell M, Revello A. Ivabradine as a treatment option for inappropriate sinus tachycardia. Rev Esp Cardiol, 2009; 62: 576-588.
17. Tardif JC, Ponikowski P, Kahan T; for the ASSOCIATE Study Investigators. Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: A 4-month, randomized, placebo-controlled trial. Eur Heart J, 2009; 30: 540-548.
18. Zhang R, Haverich A, Strüber M, Simon A, Pichlmaier M, Bara C. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia. Clin Res Cardiol, 2008, 97: 811-819.
19. Lewis RV, Lofthouse C. Adverse reactions with beta-adrenoceptor blocking drugs. An update Drug Saf, 1993; 9: 272-279.